1,443 results on '"Fogelman, I."'
Search Results
2. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells
3. Musculoskeletal System
4. The Bone Scan in Metastatic Disease
5. Bone Scintigraphy
6. Bone Tumors
7. 18F-NaF PET/CT: EANM procedure guidelines for bone imaging
8. Treatment of post-menopausal osteoporosis: beyond bisphosphonates
9. Clinical role of bisphosphonate therapy
10. Musculoskeletal
11. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)
12. Skeletal SPET
13. Vitamin D Status and Parathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab
14. Changes in bone mineral density and bone turnover in patients on ‘drug holiday’ following bisphosphonate therapy: real-life clinic setting
15. Thyroid disease
16. Bone scanning
17. The Clinical Relevance of Bone Mass Measurements
18. The Measurement of Bone Density
19. Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA
20. Differences in regional bone metabolism at the spine and hip: a quantitative study using 18F-fluoride positron emission tomography
21. Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
22. Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women
23. Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness
24. ‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass
25. The effect of weight and weight change on the long-term precision of spine and hip DXA measurements
26. Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
27. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease
28. Significant differences in UK and US female bone density reference ranges
29. Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy
30. Peripheral and Central Measurements of Bone Mineral Density Are Equally Strongly Associated with Clinical Risk Factors for Osteoporosis
31. Predicting the Risk of Fracture at Any Site in the Skeleton: Are All Bone Mineral Density Measurement Sites Equally Effective?
32. Correction to: 18F-NaF PET/CT: EANM procedure guidelines for bone imaging
33. Dual X-ray Absorptiometry: Clinical Evaluation of a New Cone-Beam System
34. Abstracts of original contributions ASNC 2004 9th annual scientific session September 3-–October 3, 2004 New York, New York
35. Can the WHO definition of osteoporosis be applied to multi-site axial transmission quantitative ultrasound?
36. Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss
37. Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
38. Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone
39. Effect of a 300 000-IU Loading Dose of Ergocalciferol (Vitamin D2) on Circulating 1,25(OH)2-Vitamin D and Fibroblast Growth Factor-23 (FGF-23) in Vitamin D Insufficiency
40. A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip
41. Multisite Quantitative Ultrasound: Colles’ Fracture Discrimination in Postmenopausal Women
42. COLIA1 Sp1 Polymorphism Predicts Response of Femoral Neck Bone Density to Cyclical Etidronate Therapy
43. Changes in QUS and BMD Measurements with Antiresorptive Therapy: A Two-Year Longitudinal Study
44. Effects of 8 Years of Treatment with Tibolone 2.5 mg Daily on Postmenopausal Bone Loss
45. Multisite Quantitative Ultrasound: Precision, Age- and Menopause-Related Changes, Fracture Discrimination, and T-score Equivalence with Dual-Energy X-ray Absorptiometry
46. Does the Combination of Quantitative Ultrasound and Dual-Energy X-Ray Absorptiometry Improve Fracture Discrimination?
47. Vertebral Morphometry: A Comparison of Long-Term Precision of Morphometric X-ray Absorptiometry and Morphometric Radiography in Normal and Osteoporotic Subjects
48. The Effect of Weight Change on Total Body Dual-Energy X-ray Absorptiometry: Results from a Clinical Trial
49. Visual Assessment of Vertebral Deformity by X-ray Absorptiometry: A Highly Predictive Method to Exclude Vertebral Deformity
50. Vertebral Morphometry: Repeat Scan Precision Using the Lunar Expert-XL and the Hologic 4500A. A Study for the “WISDOM” RCT of Hormone Replacement Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.